Trial intelligence / Profile preview

Green Propolis Extract (EPP-AF) for Inflammation in Hemodialysis

NCT04072341Phase 2Completed

Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Start
Aug 2019
Primary completion
Dec 2019
Modality
Hydrogel Systems, Transdermal Patches
Countries
1
01

Overview

A Phase 2 trial of Brazilian green propolis extract in end stage renal disease (ESRD), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Aug 2019; status: completed.

02

Drugs

Brazilian green propolis extract
03

Conditions

end stage renal disease (ESRD)

Beyond the preview

Go deeper on NCT04072341.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04072341.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call